User profiles for P. Barreras

Paula Barreras

Cedars-Sinai Medical Center
Verified email at cshs.org
Cited by 1651

Zika virus–associated neurological disease in the adult: Guillain–Barré syndrome, encephalitis, and myelitis

LS Muñoz, P Barreras, CA Pardo - Seminars in reproductive …, 2016 - thieme-connect.com
Zika virus (ZIKV) has caused a major infection outbreak in the Americas since 2015. In
parallel with the ZIKV epidemic, an increase in cases of neurological disorders which include …

Clinical features and diagnosis of neurosarcoidosis–review article

P Barreras, BJ Stern - Journal of neuroimmunology, 2022 - Elsevier
… (O) with associated nodular leptomeningeal enhancement in the frontal and parietal lobes
(P). … Barreras and Dr. Stern contributed to the writing of the manuscript and the making of the …

Methotrexate-related pulmonary complications in rheumatoid arthritis.

P Barrera, RF Laan, PL Van Riel… - Annals of the …, 1994 - ncbi.nlm.nih.gov
… Nijmegen, The Netherlands P Barrera RFJMLaan PLCM van Riel P N R Dekhuijen* AM Th
… We are also grateful to P Donnelly and JW M van der Meer for the revision of this manuscript…

Guillain–Barré syndrome associated with Zika virus infection in Colombia

…, LS Muñoz, L Osorio, P Barreras… - … England Journal of …, 2016 - Mass Medical Soc
Background Zika virus (ZIKV) infection has been linked to the Guillain–Barré syndrome.
From November 2015 through March 2016, clusters of cases of the Guillain–Barré syndrome …

Acute disseminated encephalomyelitis in 228 patients: a retrospective, multicenter US study

…, GM Hoganson, AK Yeshokumar, P Barreras… - Neurology, 2016 - AAN Enterprises
… ADEM than in adults (58% vs 21%, p = 0.007), in whom MS was diagnosed more often. … ]
0.383, p = 0.001), male sex (HR 0.394, p = 0.002), and increasing age at onset (HR 0.984, p = …

Rotenone exerts developmental neurotoxicity in a human brain spheroid model

…, P Lau, L Gribaldo, CA Pardo, P Barreras… - Toxicology and applied …, 2018 - Elsevier
… The upper right corners of the plots contain bubbles corresponding to pathways with a
strong directional change and high −log 10 p-value. All the significant pathways were down-…

Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm

MA Garcia, PV Barreras, A Lewis, G Pinilla… - Journal of the …, 2021 - Elsevier
P < 0.05) or red (P < 0.005). Analytes that are significantly higher in the control groups are
denoted as light blue (P < 0.05) or dark blue (P … shown as orange (P < 0.05) or red (P < 0.005). …

Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy

P Barreras, KC Fitzgerald, MA Mealy, JA Jimenez… - Neurology, 2018 - AAN Enterprises
Objective To assess the predictive value of the initial clinical and paraclinical features in the
differentiation of inflammatory myelopathies from other causes of myelopathy in patients with …

Celulosa chilena: avances y perspectivas de su comercio exterior.

P Barrera, O de Estudios - 2018 - sidalc.net
En la siguiente publicación, junto con revisar los avances sectoriales de las exportaciones
forestales en el período 2000-2015, se analizará la evolución de la producción de celulosa y …

Long-term effectiveness and safety of rituximab in neuromyelitis optica spectrum disorder and MOG antibody disease

P Barreras, ES Vasileiou, AG Filippatou, KC Fitzgerald… - Neurology, 2022 - AAN Enterprises
… < 0.001) and MOGAD (median ARR: pretreatment 1.9, posttreatment 0.3; p = 0.002). …
Statistical significance was considered p < 0.05. Statistical analyses were performed using …